Index
Grant: Schepens Eye Research Institute at Mass Eye and Ear — Pulmonary Fibrosis Drug (Leo Kim) (Coefficient Giving → Mass Eye and Ear)
Verdictconfirmed95%
1 check · 4/9/2026Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Our claim
entire record- Name
- Schepens Eye Research Institute at Mass Eye and Ear — Pulmonary Fibrosis Drug (Leo Kim)
- Amount
- $920,000
- Currency
- USD
- Date
- July 2021
- Notes
[Scientific Research] Open Philanthropy recommended a grant of $920,000 to Mass Eye and Ear to support research led by Leo Kim, of Mass Eye and Ear and Harvard Medical School, on a drug to treat pulmonary fibrosis in patients with COVID-19 and other causes. Pulmonary fibrosis is … expand
[Scientific Research] Open Philanthropy recommended a grant of $920,000 to Mass Eye and Ear to support research led by Leo Kim, of Mass Eye and Ear and Harvard Medical School, on a drug to treat pulmonary fibrosis in patients with COVID-19 and other causes. Pulmonary fibrosis is a chronic and often fatal lung disease that affects approximately 3.5 million people worldwide, in addition to a significant number of patients hospitalized with COVID-19. This falls within our work on scientific research, specifically within our interest in human health and wellbeing.
Source evidence
1 src · 1 checkconfirmed95%deterministic-row-match · 4/9/2026
- Name
- Schepens Eye Research Institute at Mass Eye and Ear — Pulmonary Fibrosis Drug (Leo Kim)
- Grantee
- Mass Eye and Ear
- Focus Area
- Scientific Research
- Amount
- $920,000.00
- Date
- July 202
NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Case № iIwBDKr8fIFiled 4/9/2026Confidence 95%